Apellis Pharmaceuticals Inc’s recent filing unveils that its Chief Scientific Officer Deschatelets Pascal unloaded Company’s shares for reported $3.74 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Apellis Pharmaceuticals Inc’s filing revealed that its Chief Scientific Officer Deschatelets Pascal unloaded Company’s shares for reported $3.74 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals
Apellis Pharmaceuticals Inc’s recent filing unveils that its Chief Scientific Officer Deschatelets Pascal unloaded Company’s shares for reported $3.74 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Apellis Pharmaceuticals
Apellis Pharmaceuticals Inc’s filing revealed that its Chief Scientific Officer Deschatelets Pascal unloaded Company’s shares for reported $3.74 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Apellis Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Sullivan Timothy Eugene unloaded Company’s shares for reported $0.23